/Companies

Dahlia Biosciences

1 known investors

Find your way into Dahlia Biosciences

Sign up to see every warm intro you have to Dahlia Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Dahlia Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Dahlia develops RNA Flow Assays that let researchers detect specific RNA targets at the single-cell level using standard fluorescence-based flow cytometers, enabling measurement of non-coding RNA and proteins that lack quality antibodies. It sells target-specific RNA Flow Probe Sets and universal RNA Flow Assay Reagent Kits for life sciences research applications such as validating single-cell RNA sequencing and enriching rare cell populations.

Investors · 1

Frequently asked questions

What does Dahlia Biosciences do?
Dahlia develops RNA Flow Assays that let researchers detect specific RNA targets at the single-cell level using standard fluorescence-based flow cytometers, enabling measurement of non-coding RNA and proteins that lack quality antibodies. It sells target-specific RNA Flow Probe Sets and universal RNA Flow Assay Reagent Kits for life sciences research applications such as validating single-cell RNA sequencing and enriching rare cell populations.
Who are Dahlia Biosciences's investors?
Dahlia Biosciences's investors include SOSV.